EUVIMEDEUVIMED entdecken
Crossref

Survival outcomes in small intestine tumors: The role of duodenum, jejunum, and ileum

Hongwei Wu iD, Xiaobao Yang, Wei Guo

International Journal of Cancer · 2025

DOI: 10.1002/ijc.35379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Hongwei Wu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Gastrointestinal Stromal Tumors, Duodenal Neoplasms, Ileal Neoplasms, Jejunal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Beijing Hospitals Authority Clinical medcine Development of special funding support.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Small intestine tumors are rare, with variable prognostic factors. The impact of tumor location on survival outcomes remains controversial. This study explores the influence of tumor location (duodenum, jejunum, ileum) on survival. We analyzed data from the SEER database for small intestine cancer patients diagnosed between 2010 and 2017. Survival outcomes by tumor location were assessed using the Kaplan–Meier method and competing risk models, stratified by adenocarcinoma (ADC), neuroendocrine tumor (NET), and gastrointestinal stromal tumor (GIST). Propensity score matching (PSM) was employed to adjust for confounders. The cohort included 6047 patients: 2611 with duodenum, 2584 with ileum, and 852 with jejunum tumors. ADC was predominant in the duodenum (51.4%), while NET was most common in the ileum (84.21%). Overall, the ileum tumors had the best prognosis, and duodenum tumors had the worst ( p < .001). In ADC, duodenum tumors had the poorest overall (OS) and disease‐specific survival (DSS) ( p < .001) with no significant impact of location in GIST ( p > .05). The competing risk model indicated better prognosis for jejunum versus duodenum in ADC (HR = 0.80, p = .048) and similar risks between ileum and duodenum tumors (HR = 0.99, p = .94), while location did not affect prognosis in GIST and NET ( p > .05). Post‐PSM, survival curves reconfirmed no significant difference between duodenum and ileum ADC ( p > .05). Tumor location significantly influences prognosis in small intestine ADC, with duodenum tumors showing the worst outcomes. Location was not a significant prognostic factor in GIST and NET.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal Stromal TumorsDuodenal NeoplasmsIleal NeoplasmsJejunal NeoplasmsIntestinal NeoplasmsAdenocarcinomaNeuroendocrine TumorsHumansMaleFemaleMiddle AgedAgedPrognosisSEER ProgramKaplan-Meier EstimateJejunumIleumPropensity ScoreDuodenumAdultAged, 80 and over

Stichwörter der Autor:innen

SEER programpropensity scoresmall intestine tumorsurvival analysistumor location

Autor:innen und Institutionen

  • Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • State Key Lab of Digestive Health, Beijing, China.
  • National Clinical Research Center for Digestive Diseases, Beijing, China.
  • Department of Hernia and Abdominal Wall Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Hongwei Wu

Förderung

  • Beijing Hospitals Authority Clinical medcine Development of special funding support

Zitieren

APA

Wu, H., Yang, X., & Guo, W. (2025). Survival outcomes in small intestine tumors: The role of duodenum, jejunum, and ileum. International Journal of Cancer. https://doi.org/10.1002/ijc.35379

Vancouver

Wu H, Yang X, Guo W. Survival outcomes in small intestine tumors: The role of duodenum, jejunum, and ileum. International Journal of Cancer. 2025. doi:10.1002/ijc.35379

BibTeX
@article{Wu2025,
  author = {Wu, Hongwei and Yang, Xiaobao and Guo, Wei},
  title = {Survival outcomes in small intestine tumors: The role of duodenum, jejunum, and ileum},
  journal = {International Journal of Cancer},
  year = {2025},
  doi = {10.1002/ijc.35379}
}
Kostenlos starten →